跳至主要内容
临床试验/NCT04786470
NCT04786470Unknown3 期

Transversus Abdominis Plane Catheter Following Kidney Transplantation

Western University, Canada0 个研究点目标入组 120 人开始时间: 2021年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
120
主要终点
Oral morphine equivalent (OME)

研究概览

简要总结

Continuous Infusion of Local Anesthetic After Kidney Transplantation

This is a phase III, randomized, double-blinded, sham-controlled trial comparing the use of a continuous infusion of local anesthetic via transversus abdominis plane (TAP) catheter to a saline infusion (sham) via TAP catheter along with standard postoperative analgesia in patients undergoing kidney transplantation. Patients will have a TAP catheter placed at the time of kidney transplantation by the surgical team under direct vision. They are then randomized to a continuous infusion of local anesthetic or saline for 48 hours postoperatively. Both groups will receive a standard postoperative analgesic regimen including a Patient Controlled Analgesic (PCA) pump and multimodal analgesics including acetaminophen and gabapentin.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male, female, non-binary gender, aged >18 years.
  • Undergoing a kidney transplant (deceased or living donor) as treatment for stage 5 chronic kidney disease (Glomerular filtration rate < 15ml/min) either on dialysis, or approaching dialysis
  • No history of allergy to any local anesthetic.
  • Agreement to adhere to Lifestyle Considerations (see section 5.3) throughout study duration

排除标准

  • Current use of opioid pain medications prior to kidney transplantation.
  • Known allergic reactions to components of any local anesthetic medication.
  • Prior local anesthetic systemic toxicity.
  • History of chronic pain undergoing current active treatment for the same.
  • Age <18 years (this analgesic approach has not been established in this population).
  • Unable or unwilling to use IV PCA pump for any reason (manual dexterity, cognitive impairment, patient choice etc.).
  • Multi-visceral transplantation.
  • Incision other than standard Gibson incision.
  • Unilateral or bilateral nephrectomy at time of kidney transplant.
  • Advanced liver disease.

研究组 & 干预措施

Local Anaesthetic Infusion

Active Comparator

干预措施: Ropivacaine (Drug)

Saline Infusion

Sham Comparator

干预措施: Saline (Drug)

结局指标

主要结局

Oral morphine equivalent (OME)

时间窗: 48 hours post kidney transplantation

OME in mg

次要结局

  • Visual Analog Scale pain rating(12, 24, and 48 hours post kidney transplantation)
  • Patient quality of life score(48 hours post kidney transplantation)
  • Time to return of bowel function postoperatively(Duration of admission)
  • Incidence of local anesthetic systemic toxicity(Duration of admission)
  • Postoperative adverse events (surgical)(Duration of admission)
  • Delayed graft function(Duration of admission)
  • Length of stay(Duration of admission)
  • Creatinine (mmol/L) at time of discharge(Duration of admission)

研究者

发起方
Western University, Canada
申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrew Rasmussen

Kidney and Pancreas Transplantation Fellow

Western University, Canada

相似试验